Beisland H O, Sander S
Scand J Urol Nephrol. 1986;20(2):113-7. doi: 10.3109/00365598609040558.
This first clinical report on Neodymium-YAG laser irradiation of localized prostatic cancer presents our experiences in 63 patients during 4 years. Transurethral resection extending to the capsule and subsequent laser irradiation according to our standardized treatment procedure give few complications and good functional results. Actuarial disease-free survival is 98% on one year and 80% in the 2-4 year period. The results are promising and comparable to short-term results obtained by radiotherapy and/or interstitial radioactive implants. Further experience is necessary for a definitive comparison to established treatment modalities.
这份关于钕钇铝石榴石激光照射局限性前列腺癌的首份临床报告展示了我们在4年中对63例患者的治疗经验。按照我们的标准化治疗程序，经尿道切除术延伸至包膜并随后进行激光照射，并发症少且功能效果良好。精算无病生存率在1年时为98%，在2至4年期间为80%。结果令人鼓舞，与放疗和/或间质放射性植入所获得的短期结果相当。要与既定的治疗方式进行明确比较，还需要更多经验。
